SELLAS Life Sciences Group, Inc. (SLS) Misses Q1 EPS by 18c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.47), $0.18 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Take-Two Interactive (TTWO) Reiterated at Buy by StoneX Ahead of November GTA VI Launch
• Goldman Sachs starts Viridien at Buy on exploration recovery, shares rise